Gene · 833
Papers4,113
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
601 to 620 of 4,113
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| WIPI2 enhances the vulnerability of colorectal cancer cells to erastin via bioinformatics analysis and experimental verification. | Front Oncol | 2023 | 37207153 | PubTator, text mining | PubMed |
| The application of autologous cancer immunotherapies in the age of memory-NK cells. | Front Immunol | 2023 | 37205105 | PubTator, text mining | PubMed |
| The potential of regulatory T cell-based therapies for alopecia areata. | Front Immunol | 2023 | 37205097 | PubTator, text mining | PubMed |
| Sequential therapy with supercharged NK cells with either chemotherapy drug cisplatin or anti-PD-1 antibody decreases the tumor size and significantly enhances the NK function in Hu-BLT mice. | Front Immunol | 2023 | 37197660 | PubTator, text mining | PubMed |
| CAR NK-92 cell-mediated depletion of residual TCR+ cells for ultrapure allogeneic TCR-deleted CAR T-cell products. | Blood Adv | 2023 | 37196643 | PubTator, text mining | PubMed |
| Functionality of immune cells in COVID-19 infection: development of cell-based therapeutics. | Bioimpacts | 2023 | 37193075 | PubTator, text mining | PubMed |
| Applications of Depth Minimization of Decision Trees Containing Hypotheses for Multiple-Value Decision Tables. | Entropy (Basel) | 2023 | 37190335 | PubTator, text mining | PubMed |
| Gene Targets of CAR-T Cell Therapy for Glioblastoma. | Cancers (Basel) | 2023 | 37190280 | PubTator, text mining | PubMed |
| CRISPR-Cas System: The Current and Emerging Translational Landscape. | Cells | 2023 | 37190012 | PubTator, text mining | PubMed |
| Transcriptomic Approaches in Studies on and Applications of Chimeric Antigen Receptor T Cells. | Biomedicines | 2023 | 37189725 | PubTator, text mining | PubMed |
| The Current Status and Future Perspectives of Chimeric Antigen Receptor-Engineered T Cell Therapy for the Management of Patients with Endometrial Cancer. | Curr Issues Mol Biol | 2023 | 37185744 | PubTator, text mining | PubMed |
| Pancreatic Ductal Adenocarcinoma and Immune Checkpoint Inhibitors: The Gray Curtain of Immunotherapy and Spikes of Lights. | Curr Oncol | 2023 | 37185406 | PubTator, text mining | PubMed |
| Kymriah® (tisagenlecleucel) - An overview of the clinical development journey of the first approved CAR-T therapy. | Hum Vaccin Immunother | 2023 | 37185251 | PubTator, text mining | PubMed |
| 10th antibody industrial symposium: new developments in antibody and adoptive cell therapies. | MAbs | 2023 | 37184206 | PubTator, text mining | PubMed |
| A systematic review and meta-analysis of CD22 CAR T-cells alone or in combination with CD19 CAR T-cells. | Front Immunol | 2023 | 37180149 | PubTator, text mining | PubMed |
| T cell immunotherapy for cervical cancer: challenges and opportunities. | Front Immunol | 2023 | 37180106 | PubTator, text mining | PubMed |
| Adoptive Immunotherapy and High-Risk Myeloma. | Cancers (Basel) | 2023 | 37174099 | PubTator, text mining | PubMed |
| Biophysical and mechanobiological considerations for T-cell-based immunotherapy. | Trends Pharmacol Sci | 2023 | 37172572 | PubTator, text mining | PubMed |
| CD38 as a pan-hematologic target for chimeric antigen receptor T cells. | Blood Adv | 2023 | 37171449 | PubTator, text mining | PubMed |
| Oxidative stress in the tumor microenvironment in gastric cancer and its potential role in immunotherapy. | FEBS Open Bio | 2023 | 37171226 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/833/papers?page=31